Last reviewed · How we verify
NCT00339690
Dust Mite Allergen Reduction Study
Phase 2 trial testing MITE-T-FASTtest kit in Allergy in 60 participants. Completed in 11 February 2009.
11 February 2009
Quick facts
| Lead sponsor | National Institute of Environmental Health Sciences (NIEHS) |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | other |
| Enrollment | 60 |
| Start date | 6 June 2005 |
| Primary completion | 11 February 2009 |
| Estimated completion | 11 February 2009 |
| Sites | 1 location across United States |
Drugs / interventions tested
- MITE-T-FASTtest kit
Conditions studied
- Allergy — all drugs for Allergy →
Sponsor
National Institute of Environmental Health Sciences (NIEHS)
Who can join
Adults 5 to 15, any sex, with Allergy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will determine whether use of an in-home test kit results in decreased dust mite allergen levels in homes of children who are sensitive or allergic to dust mites. Dust mite allergens come from dust mites - microscopic spider-like animals that feed on house dust. Dust mites are common anywhere there is dust, such as in carpeting and beds. Some people are allergic to dust mite allergens and may develop asthma from living near them. People who live in the Research Triangle Park area of North Carolina who have a child between 5 and 15 years old with a dust mite allergy or sensitivity may be eligible for this study. Participants must plan to remain in the same house for at least 12 months from the start of the study. At least half the floor of the child's room must be carpeted. Participants are given materials on how to reduce dust mite allergens in their home. Study staff visit participants' homes three times over a 12-month period to ask questions about the home, home cleaning habits, and participants' experiences with home test kits (see below) for measuring dust mite allergen. At each visit, staff collect dust samples from the child's bedroom, the parents' bedroom, and the living room. The dust samples are analyzed in the laboratory for dust mite allergens and the results are given to the participants at the end of the study. Participants are also given four home test kits for measuring dust mite allergen in the home. At the first home visit, staff instruct the participants on how to use the kits and answer any questions they may have. The kits are mailed at certain times during the study for the participants to use to measure allergen and send the results to the study investigators in a pre-paid addressed envelope. A control group is given educational materials but no test kits.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Efficacy of an in-home test kit in reducing dust mite allergen levels: results of a randomized controlled pilot study.
Winn AK, Salo PM, Klein C, Sever ML, et al · · 2016 · cited 8× · PMID 26308287 · DOI 10.3109/02770903.2015.1072721
Verify or expand the search:
- PubMed search for NCT00339690
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Allergy
Currently open trials in the same condition.
- NCT05997784 — Study of Indoor Air Pollutants and Their Impact in Childhood Health and Wellbeing · active not recruiting
- NCT06390878 — Nationwide Research on the Rewilding of Kindergarten Yards · NA · recruiting
- NCT06248957 — SYSTEMS-LEVEL ANALYSES OF IMMUNE DYSREGULATION · recruiting
- NCT05449756 — A Follow-up Study With Children Who Participated in the TEMPO Study in Their First Year of Life · recruiting
- NCT06192914 — EPAP, Interviewstudy · recruiting
Other National Institute of Environmental Health Sciences (NIEHS) trials
Trials by the same sponsor.
- NCT07111065 — FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) · Phase 2 · recruiting
- NCT06991751 — A Natural History of Cardiometabolic Disease Among US Bhutanese: Developing the Cross-Sectional Bhutanese Community of C · not yet recruiting
- NCT07437976 — A Natural History of Genetic and Environmental Predictors of Pubertal Timing Among Youth With Obesity · not yet recruiting
- NCT06325696 — H01 in Adults With Interstitial Lung Disease (The SOLIS Study) · Phase 2 · recruiting
- NCT05666739 — NIEHS Repository of Stored Biological Samples for Future Use · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00339690 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Institute of Environmental Health Sciences (NIEHS)
- Last refreshed: 16 December 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00339690.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing